Reinventing R&D: collaborating for tomorrow’s therapies | Dr. Uli Stilz, Bio Innovation Hub at Novo Nordisk
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
This is Signal. The new voice for next generation biotech leaders, presented by Nucleate.
Get the email newsletter and unlock access to members-only content and updates
Processing your application
Please check your inbox and click the link to confirm your subscription.
There was an error sending the email
Get started with our best stories
Introducing the Nucleate Network: A New Series Connecting Our Global Community
Through articles based on personal interviews, we’ll shine the spotlight on the incredible individuals who make our community extraordinary and who make Nucleate possible.
Breaking Barriers in Women's Health: The Vagina Business
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Ecosystems of Innovation: Finding Entrepreneurial Academics in the US
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
Biotech journalism & scaling new heights for a good cause
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
Navigating the Biotech VC Landscape in Chicago
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Biotech Venture Capital Activity in Brazil
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Introducing Signal
The human story of biotechnology, and how it will change life as we know it.
Rewriting Genetic Medicine with Epigenetic Editing | Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine
A conversation with Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine.
Nucleate Network: The Origins of Nucleate
Written by Lauren Clubb Welcome to the debut of the Nucleate Network! This new series on Signal joins our lineup of content, including Hidden Layers, Ecosystem Reports, and the Nucleate Podcast. If you're discovering Nucleate for the first time, we're thrilled to have you! Nucleate is...
Introducing the Nucleate Network: A New Series Connecting Our Global Community
Through articles based on personal interviews, we’ll shine the spotlight on the incredible individuals who make our community extraordinary and who make Nucleate possible.
Revolutionizing Gene Therapy with AI-Powered Capsid Engineering | Eric Kelsic, Dyno Tx
A conversation with Eric Kelsic, CEO & Co-founder at Dyno Tx.
From Sequencing the Human Genome to Venture Capital: Biotech Lessons with Peter Barrett, Atlas Venture
A conversation with Peter Barrett, Partner legacy funds at Atlas Venture.
Designing Programmable Genetic Medicines | Jake Becraft, CEO & Co-founder at Strand Therapeutics
A conversation with CEO and co-founder, Jake Becraft of Strand Therapeutics.
Recommended
